Ann: US Clinical Trial Results Published, page-25

A few seem to try and insinuate the  online  access journals are of a lesser quality. As a scientist, i can assure you they are becoming commonplace and are just a new channel for getting results out. They are not an avenue for substandard publishing. I post a link here to a review to de-bunk this myth. https://www.aje.com/en/arc/open-access-myths/

Make no mistake, this was company making news today. The missing piece of the jigsaw to serious revenue generation. I can only assume a lot of stale holders who had their capital locked up for about 12 months exited today at any price. I'm hoping for a chain of follow up announcements starting with an investor call and hopefully extending to new distribution in the UK, orders placed in existing countries and eventually sales for the Q3 4C.